{"name":"Myeloid Therapeutics","slug":"myeloid-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNdHVKaVdobWdBVVhvNEJ1TEF6TlRvVWk4SUVxaHJrdDcxSXQtVUVnNklPdlhEYTVfbjA4WE9jVmpFeHdZM1R3ektSM0IzTjJLdFdkNmVoWE5ZMzg3anVsMEdiWXBnQ3JoQjl2aUNFSVhsRUxaM0NVUXNhdkZvcXo3M2VpQnJzRWJZM3ppVENrZDNoM0xWYjd1M3NqOWZnSjJhTnVwM2RTZFFsWUN0ampzMnluYUFNdEVLSEN2bFRxLUpNdmw4cElWMXhIbVRmOEduejhTQ1dvR2NJVUlFRmUyVElucFhHanN2dTFZaWVkOXpsRE1ueTRON1poX3pYV0R5MHZJSV9JSGMwd1ZxOTloWXlsM05OZUk0TjJNa21Xa3hmU2JheVE?oc=5","date":"2026-03-25","type":"regulatory","source":"Business Wire","summary":"Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) - Business Wire","headline":"Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNWk5QY1A2c0Ryc0dobWlGYk1rdUZpQnVNeXQ4NWh2RENmMXh2UjNzcXJXU1piVEstcElUSk82Q2ZXUFhDaHo4SE1uamJBdDJ5LWFoTHZ2UUNTdFB0b3ZuNzUxaXlyMVU3SnFobTdlOFBwZzRrTVlJVHZVV2M1UTZSWThfMngtS1pFRVJr?oc=5","date":"2025-12-04","type":"trial","source":"Yahoo Finance","summary":"Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Yahoo Finance","headline":"Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Dom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQNy15ZUhxdUg2WTVoOUNHcWhRMTNkV2RIZjlTSzZuYTR5aTJEa3hIT0dWXy12M0RmZWkxdHJpUng4M2JmdFpfR3dHNDV4NjdfME55aThsdlVPMm5VSm01NWdBajE1R2NyLW54SUVaVWw0WjZjSzYzR2FUVnlzY0NqYUkyd20tdmdKb0J3bFRTX0poUXhUbXZNVi1vQnp4bEJ4?oc=5","date":"2025-11-19","type":"pipeline","source":"Fierce Biotech","summary":"GSK pens $50M LTZ pact to join Big Pharma peers in emerging myeloid cell engager space - Fierce Biotech","headline":"GSK pens $50M LTZ pact to join Big Pharma peers in emerging myeloid cell engager space","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPQTNPenkzbldHWlZCdTViemJzb0JHdUJqNXJkai1YaFR4T3cwSDFvbFkzMkIzTDUyejVOTVA2X1NHcEhOd2xkdzNIdUd6enkwVWtYYVdLaHJZbHVBZkFFR0ljYlkwZThUcV94M29CcnlzdmI4R1hoNWlMSHk3aHFYakl0M3pNVDBfcFdOdFZTVENiek4xSjdOdE5sY2hpYTcxV2RKckJ5QmFCQlVLNUUwVVhMNU5vQnNkbUJwVjctR3AwcWVzc19LMlk0dEFSZWVWLUJWV2hqOVU0d2dacE9aZE9panFiSXFBXzFDbTZHeGljQ01tODRfamxzMnBxOGhzVjJIQXVVWFFQYWg4RG1qamx3SHl1TVl3?oc=5","date":"2025-11-03","type":"trial","source":"PR Newswire","summary":"CREATE Medicines to Present Late-Breaking Clinical Data on MT-302 at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting - PR Newswire","headline":"CREATE Medicines to Present Late-Breaking Clinical Data on MT-302 at the Society for Immunotherapy of Cancer (SITC) 40th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNdFRTWmJkX0dMRkVkYkJvYzk5WUxjeXBxbzA4dkhqaE1DSTVuRExKSjl2bW53Q3BpV1o5UHI3blBkdnJ6Z2F1UjE0b05PWHNUQUdDMWNScnVOUDlBc1N5cXpMX3NMOG1ubk5rb0xDUS1jczBZdU8zUTM3bk9XdjJMM19PbV9rbGk4QjdxUERSMGVZdXFld3Nsc1gyajQ4ZV9neC1haEJyWENrUVdhVU94VWdVLXc4NE00WG5UeFoyNjdERzFIZVZ6LQ?oc=5","date":"2025-10-22","type":"deal","source":"European Pharmaceutical Review","summary":"Ipsen strikes €1bn deal to acquire French biotech ImCheck Therapeutics - European Pharmaceutical Review","headline":"Ipsen strikes €1bn deal to acquire French biotech ImCheck Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNnNZalB6TDQzcEhlZWpRQXVhNkhpWV9MM0o4dmlfWjEzRVAtMUVrenZHVFdpblE3Wnl1MjlmN1pzTmFLQThOdllCZjJkR2J6M0xOZm5UYTIwSmJsVkdIUWdIbF9TZmVEQXZLVmEyVC1Id3VFVFdvSTVYdmh0UWlfbnBqdGRKY0hDRlVGOVlZN3RRdjdaX1lLOGptRFlsTnNXZUR3b3RlQnk?oc=5","date":"2025-10-21","type":"pipeline","source":"Fierce Pharma","summary":"Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises $20M - Fierce Pharma","headline":"Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises $20M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQeTFwbXZxTGxTRTktTGJRVzZ6LTBHdFhkWWczVDMyR1dyLXhSVzFkMXZacml6RDhkQ1Nuejl2NlJtWGVocy1oT2JZYUpydE5UMFgyakFwdE1uUzRZbklaMDQydzJsQ1l3dEE1NXppNTZzTk9iZmpqeTg2bk5BUHBlYXlsREp1YnhXWnFsZHA3ZEdrYUpLU1EtcW5mSjAzaXpqMkJ6anh2a180M3hCYmlNMlJBWQ?oc=5","date":"2025-10-06","type":"pipeline","source":"Fierce Pharma","summary":"Myeloid Therapeutics creates new identity after pipeline outgrows its name - Fierce Pharma","headline":"Myeloid Therapeutics creates new identity after pipeline outgrows its name","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOU2xMQXo3MURKaF82XzdRWGs2alBXT3dTM1VrQm1CbVRDTmFOV25tc0ZaVXY3WUtFTjFCcTZhQXFid1FnN01xUkxLbVhjcHpNS09oSGNsb1Ytck1leWpZQi1TaEh5TmR4TFF6TWtaMlBNLW52SUlRUXF6bmlHY01oSFBHZ1pIcWJRcTZfbGVwYmdKMFR4OHVQekVDbmRRRGZQYnVzOU4wR1NmMm5MbWE4MU5Sa2JvZURlSGlXaUs1QXN4Nk5uOV8zTnF1SFV2VkdhQzJRN2lxdXFJanZNd2NvNTQwYlhfbUlSWHhYZ2JjcHEwZEdpUXNtcjBiaEtILUtSTk1rZklnS2FHWnhmQ2wtMkE4MTQtWHQwYU1Pd1JiZw?oc=5","date":"2025-10-06","type":"pipeline","source":"PR Newswire","summary":"Myeloid Therapeutics Rebrands as CREATE Medicines, Focused on Transforming Immunotherapy Through RNA-Based In Vivo Multi-Immune Programming - PR Newswire","headline":"Myeloid Therapeutics Rebrands as CREATE Medicines, Focused on Transforming Immunotherapy Through RNA-Based In Vivo Multi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQczBEdVMycUVpQzBfVG1oc0k5eExmTzAycmlESnpHWkpBOXl4RFA4elRrTEhNT2c2QTg4RUk3bWRHUTNvczV6d3NoQWI4aDlLY1BvbWNKVnc0WEt4dDBuSVpwbWlKOVFnUDBkOXhrMXowV0U0b19Dbklaako2TklyeDFaYXJiMXNVUl9SejgwNUpNSWZxcHJ4UmtHN2szUzg?oc=5","date":"2025-07-30","type":"pipeline","source":"The Pharma Letter","summary":"LTZ and Lilly link up on myeloid engager therapeutics - The Pharma Letter","headline":"LTZ and Lilly link up on myeloid engager therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOT1lId3hoRjBnZU9fQmxGQnpTUlBaQTlodExtRm1GdVFnMm9PclhxbTBXMjNhUXlLVmNndG8yeGE2MXZvdmdqbm8zeERzNmRZNEptNTJ1Y3JZWXo2WEwtS3pLOVNzY0hSay1Zc2JDRnQtbkZNMlBSREdYMWtnVnJlY1NIRFBGZ1QzWWhxdE9WSlJYb2FwS0lzNnZWT0FiSTg1RWNIcDh2TURsaXlqUjRxNG1BajdoejRsZXFZUFFYSzA?oc=5","date":"2023-05-19","type":"pipeline","source":"Contract Pharma","summary":"Myeloid Therapeutics Gets $73M Financing for mRNA-based Immunotherapy Pipeline - Contract Pharma","headline":"Myeloid Therapeutics Gets $73M Financing for mRNA-based Immunotherapy Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5UeVp0X29VNmhIVk1QaVdHUHdXUTdCbktYQjNmV1ZDNFNvVVVNTWtleGpETy1OSzlxLVFsdFRmMWhoUkl4bjlYWWtldzFKUlVkT0ktdUloZDZBeEhhUXdldlM4cWhRb0p6V2g2VDg2OVBOZWJoMU5YbWFiWkc?oc=5","date":"2021-01-06","type":"pipeline","source":"statnews.com","summary":"Siddhartha Mukherjee forms his second biotech company, focused on using cell therapy for solid tumors - statnews.com","headline":"Siddhartha Mukherjee forms his second biotech company, focused on using cell therapy for solid tumors","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}